Native to the Amazon, cat’s claw has a long history of traditional use for treatment of a wide range of inflammatory conditions. It also has been adopted by the Lyme community as a primary herb for use in treating Lyme disease.
Cat’s claw is considered an immunomodulator, meaning it calms an overactive immune system (reducing inflammation), but at the same time, enhances how well the immune system works. Benefits include potent anti-inflammatory properties and historical use for treatment of arthritis. It is known to increase WBCs, including B and T lymphocytes, natural killer (NK) cells, and granulocytes.
Cat’s claw is also known to enhance a specific type of natural killer cell, called CD 57, which is deficient in Lyme disease. Cat’s claw has also demonstrated healing properties for the GI tract (beneficial for healing leaky gut).
Primary herb for Lyme disease and gastrointestinal restoration. Cat’s claw is antiprotozoal and may provide coverage against Babesia.
Suggested dosage: 400-800 mg (inner bark standardized to 3% alkaloids or 10:1 concentrate inner bark is preferred) two to three times daily. It is especially important to take this herb with food, as it is activated by stomach acid. If you take acid-blocking drugs, cat’s claw will have limited value.
Side effects: occasional stomach upset, but generally very well tolerated.
If you search for cat’s claw, sooner or later you will come across information suggesting that “TOA-free” cat’s claw is superior to standard cat’s claw. It is promoted by the Nutramedix company to support their product, Samento. There is no independent research supporting this claim. All independent experts support use of standard cat’s claw as the best option for herbal medicine.
1. de Paula LC, Fonseca F, Perazzo F, et al. Uncaria tomentosa (cat’s claw) improves quality of life in patients with advanced solid tumors. J Altern Complement Med. 2015;21(1):22-30.
2. Rojas-Duran R, González-Aspajo G, Ruiz-Martel C, et al. Anti-inflammatory activity of Mitraphylline isolated from Uncaria tomentosa bark. J Ethnopharmacol. 2012;143(3):801-804.
3. Domingues A, Sartori A, Valente LM, Golim MA, Siani AC, Viero RM. Uncaria tomentosa aqueous-ethanol extract triggers an immunomodulation toward a Th2 cytokine profile. Phytother Res. 2011;25(8):1229-1235.
4. Allen-Hall L, Arnason JT, Cano P, Lafrenie RM. Uncaria tomentosa acts as a potent TNF-alpha inhibitor through NF-kappaB. J Ethnopharmacol. 2010;127(3):685-693.
5. Heitzman ME, Neto CC, Winiarz E, Vaisberg AJ, Hammond GB. Ethnobotany, phytochemistry and pharmacology of Uncaria (Rubiaceae). Phytochemistry. 2005;66(1):5-29.
6. Sandoval M, Okuhama NN, Zhang XJ, et al. Anti-inflammatory and antioxidant activities of cat’s claw (Uncaria tomentosa and Uncaria guianensis) are independent of their alkaloid content. Phytomedicine. 2002;9(4):325-337.
7. Reis SR, Valente LM, Sampaio AL, et al. Immunomodulating and antiviral activities of Uncaria tomentosa on human monocytes infected with Dengue Virus-2. Int Immunopharmacol. 2008;8(3):468-476.
8. Mammone T, Akesson C, Gan D, Giampapa V, Pero RW. A water soluble extract from Uncaria tomentosa (Cat’s Claw) is a potent enhancer of DNA repair in primary organ cultures of human skin. Phytother Res. 2006;20(3):178-183.
9. Gonçalves C, Dinis T, Batista MT. Antioxidant properties of proanthocyanidins of Uncaria tomentosa bark decoction: a mechanism for anti-inflammatory activity. Phytochemistry. 2005;66(1):89-98.
10. Williams JE. Review of antiviral and immunomodulating properties of plants of the Peruvian rainforest with a particular emphasis on Una de Gato and Sangre de Grado. Altern Med Rev. 2001;6(6):567-579.
11. Sandoval-Chacón M, Thompson JH, Zhang XJ, et al. Antiinflammatory actions of cat’s claw: the role of NF-kappaB. Aliment Pharmacol Ther. 1998;12(12):1279-1289.